<!DOCTYPE html>
<!--
==============================================================================
           "GitHub HTML5 Pandoc Template" v2.1 — by Tristano Ajmone           
==============================================================================
Copyright © Tristano Ajmone, 2017, MIT License (MIT). Project's home:

- https://github.com/tajmone/pandoc-goodies

The CSS in this template reuses source code taken from the following projects:

- GitHub Markdown CSS: Copyright © Sindre Sorhus, MIT License (MIT):
  https://github.com/sindresorhus/github-markdown-css

- Primer CSS: Copyright © 2016-2017 GitHub Inc., MIT License (MIT):
  http://primercss.io/

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
The MIT License 

Copyright (c) Tristano Ajmone, 2017 (github.com/tajmone/pandoc-goodies)
Copyright (c) Sindre Sorhus <sindresorhus@gmail.com> (sindresorhus.com)
Copyright (c) 2017 GitHub Inc.

"GitHub Pandoc HTML5 Template" is Copyright (c) Tristano Ajmone, 2017, released
under the MIT License (MIT); it contains readaptations of substantial portions
of the following third party softwares:

(1) "GitHub Markdown CSS", Copyright (c) Sindre Sorhus, MIT License (MIT).
(2) "Primer CSS", Copyright (c) 2016 GitHub Inc., MIT License (MIT).

Permission is hereby granted, free of charge, to any person obtaining a copy
of this software and associated documentation files (the "Software"), to deal
in the Software without restriction, including without limitation the rights
to use, copy, modify, merge, publish, distribute, sublicense, and/or sell
copies of the Software, and to permit persons to whom the Software is
furnished to do so, subject to the following conditions:

The above copyright notice and this permission notice shall be included in all
copies or substantial portions of the Software.

THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR
IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE
AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER
LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM,
OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE
SOFTWARE.
==============================================================================-->
<html>
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <title>Hypertensive Emergencies MeG-CLS-100</title>
  <style type="text/css">
@charset "UTF-8";.markdown-body{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;color:#24292e;font-family:-apple-system,system-ui,BlinkMacSystemFont,"Segoe UI",Helvetica,Arial,sans-serif,"Apple Color Emoji","Segoe UI Emoji","Segoe UI Symbol";font-size:16px;line-height:1.5;word-wrap:break-word;box-sizing:border-box;min-width:200px;max-width:980px;margin:0 auto;padding:45px}.markdown-body a{color:#0366d6;background-color:transparent;text-decoration:none;-webkit-text-decoration-skip:objects}.markdown-body a:active,.markdown-body a:hover{outline-width:0}.markdown-body a:hover{text-decoration:underline}.markdown-body a:not([href]){color:inherit;text-decoration:none}.markdown-body strong{font-weight:600}.markdown-body h1,.markdown-body h2,.markdown-body h3,.markdown-body h4,.markdown-body h5,.markdown-body h6{margin-top:24px;margin-bottom:16px;font-weight:600;line-height:1.25}.markdown-body h1{font-size:2em;margin:.67em 0;padding-bottom:.3em;border-bottom:1px solid #eaecef}.markdown-body h2{padding-bottom:.3em;font-size:1.5em;border-bottom:1px solid #eaecef}.markdown-body h3{font-size:1.25em}.markdown-body h4{font-size:1em}.markdown-body h5{font-size:.875em}.markdown-body h6{font-size:.85em;color:#6a737d}.markdown-body img{border-style:none}.markdown-body svg:not(:root){overflow:hidden}.markdown-body hr{box-sizing:content-box;height:.25em;margin:24px 0;padding:0;overflow:hidden;background-color:#e1e4e8;border:0}.markdown-body hr::before{display:table;content:""}.markdown-body hr::after{display:table;clear:both;content:""}.markdown-body input{margin:0;overflow:visible;font:inherit;font-family:inherit;font-size:inherit;line-height:inherit}.markdown-body [type=checkbox]{box-sizing:border-box;padding:0}.markdown-body *{box-sizing:border-box}.markdown-body blockquote{margin:0}.markdown-body ol,.markdown-body ul{padding-left:2em}.markdown-body ol ol,.markdown-body ul ol{list-style-type:lower-roman}.markdown-body ol ol,.markdown-body ol ul,.markdown-body ul ol,.markdown-body ul ul{margin-top:0;margin-bottom:0}.markdown-body ol ol ol,.markdown-body ol ul ol,.markdown-body ul ol ol,.markdown-body ul ul ol{list-style-type:lower-alpha}.markdown-body li>p{margin-top:16px}.markdown-body li+li{margin-top:.25em}.markdown-body dd{margin-left:0}.markdown-body dl{padding:0}.markdown-body dl dt{padding:0;margin-top:16px;font-size:1em;font-style:italic;font-weight:600}.markdown-body dl dd{padding:0 16px;margin-bottom:16px}.markdown-body code{font-family:SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace}.markdown-body pre{font:12px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;word-wrap:normal}.markdown-body blockquote,.markdown-body dl,.markdown-body ol,.markdown-body p,.markdown-body pre,.markdown-body table,.markdown-body ul{margin-top:0;margin-bottom:16px}.markdown-body blockquote{padding:0 1em;color:#6a737d;border-left:.25em solid #dfe2e5}.markdown-body blockquote>:first-child{margin-top:0}.markdown-body blockquote>:last-child{margin-bottom:0}.markdown-body table{display:block;width:100%;overflow:auto;border-spacing:0;border-collapse:collapse}.markdown-body table th{font-weight:600}.markdown-body table td,.markdown-body table th{padding:6px 13px;border:1px solid #dfe2e5}.markdown-body table tr{background-color:#fff;border-top:1px solid #c6cbd1}.markdown-body table tr:nth-child(2n){background-color:#f6f8fa}.markdown-body img{max-width:100%;box-sizing:content-box;background-color:#fff}.markdown-body code{padding:.2em 0;margin:0;font-size:85%;background-color:rgba(27,31,35,.05);border-radius:3px}.markdown-body code::after,.markdown-body code::before{letter-spacing:-.2em;content:" "}.markdown-body pre>code{padding:0;margin:0;font-size:100%;word-break:normal;white-space:pre;background:0 0;border:0}.markdown-body .highlight{margin-bottom:16px}.markdown-body .highlight pre{margin-bottom:0;word-break:normal}.markdown-body .highlight pre,.markdown-body pre{padding:16px;overflow:auto;font-size:85%;line-height:1.45;background-color:#f6f8fa;border-radius:3px}.markdown-body pre code{display:inline;max-width:auto;padding:0;margin:0;overflow:visible;line-height:inherit;word-wrap:normal;background-color:transparent;border:0}.markdown-body pre code::after,.markdown-body pre code::before{content:normal}.markdown-body .full-commit .btn-outline:not(:disabled):hover{color:#005cc5;border-color:#005cc5}.markdown-body kbd{box-shadow:inset 0 -1px 0 #959da5;display:inline-block;padding:3px 5px;font:11px/10px SFMono-Regular,Consolas,"Liberation Mono",Menlo,Courier,monospace;color:#444d56;vertical-align:middle;background-color:#fcfcfc;border:1px solid #c6cbd1;border-bottom-color:#959da5;border-radius:3px;box-shadow:inset 0 -1px 0 #959da5}.markdown-body :checked+.radio-label{position:relative;z-index:1;border-color:#0366d6}.markdown-body .task-list-item{list-style-type:none}.markdown-body .task-list-item+.task-list-item{margin-top:3px}.markdown-body .task-list-item input{margin:0 .2em .25em -1.6em;vertical-align:middle}.markdown-body::before{display:table;content:""}.markdown-body::after{display:table;clear:both;content:""}.markdown-body>:first-child{margin-top:0!important}.markdown-body>:last-child{margin-bottom:0!important}.Alert,.Error,.Note,.Success,.Warning{padding:11px;margin-bottom:24px;border-style:solid;border-width:1px;border-radius:4px}.Alert p,.Error p,.Note p,.Success p,.Warning p{margin-top:0}.Alert p:last-child,.Error p:last-child,.Note p:last-child,.Success p:last-child,.Warning p:last-child{margin-bottom:0}.Alert{color:#246;background-color:#e2eef9;border-color:#bac6d3}.Warning{color:#4c4a42;background-color:#fff9ea;border-color:#dfd8c2}.Error{color:#911;background-color:#fcdede;border-color:#d2b2b2}.Success{color:#22662c;background-color:#e2f9e5;border-color:#bad3be}.Note{color:#2f363d;background-color:#f6f8fa;border-color:#d5d8da}.Alert h1,.Alert h2,.Alert h3,.Alert h4,.Alert h5,.Alert h6{color:#246;margin-bottom:0}.Warning h1,.Warning h2,.Warning h3,.Warning h4,.Warning h5,.Warning h6{color:#4c4a42;margin-bottom:0}.Error h1,.Error h2,.Error h3,.Error h4,.Error h5,.Error h6{color:#911;margin-bottom:0}.Success h1,.Success h2,.Success h3,.Success h4,.Success h5,.Success h6{color:#22662c;margin-bottom:0}.Note h1,.Note h2,.Note h3,.Note h4,.Note h5,.Note h6{color:#2f363d;margin-bottom:0}.Alert h1:first-child,.Alert h2:first-child,.Alert h3:first-child,.Alert h4:first-child,.Alert h5:first-child,.Alert h6:first-child,.Error h1:first-child,.Error h2:first-child,.Error h3:first-child,.Error h4:first-child,.Error h5:first-child,.Error h6:first-child,.Note h1:first-child,.Note h2:first-child,.Note h3:first-child,.Note h4:first-child,.Note h5:first-child,.Note h6:first-child,.Success h1:first-child,.Success h2:first-child,.Success h3:first-child,.Success h4:first-child,.Success h5:first-child,.Success h6:first-child,.Warning h1:first-child,.Warning h2:first-child,.Warning h3:first-child,.Warning h4:first-child,.Warning h5:first-child,.Warning h6:first-child{margin-top:0}h1.title,p.subtitle{text-align:center}h1.title.followed-by-subtitle{margin-bottom:0}p.subtitle{font-size:1.5em;font-weight:600;line-height:1.25;margin-top:0;margin-bottom:16px;padding-bottom:.3em}div.line-block{white-space:pre-line}
  </style>
  <style type="text/css">code{white-space: pre;}</style>
  <!--[if lt IE 9]>
    <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.7.3/html5shiv-printshiv.min.js"></script>
  <![endif]-->
</head>
<body>
<article class="markdown-body">
<h1 id="hypertensive-emergencies">Hypertensive Emergencies</h1>
<h2 id="executive-summary"><em>Executive summary</em></h2>
<h2 id="introduction">Introduction</h2>
<p>Hypertensive emergencies encompass a spectrum of clinical presentations in which uncontrolled blood pressures (BPs) lead to progressive or impending end-organ dysfunction. Blood-pressure elevations above 180/110 mm Hg can result in acute injury to the heart, brain, and the microvasculature.</p>
<p>If acute hypertension-mediated target-organ damage is present alongside BP elevation of &gt; 180/110, the condition is labelled <strong>hypertensive emergency</strong> and demands immediate and aggressive treatment to limit progressive injury.</p>
<p>Acutely elevated blood pressure in the absence of acute target-organ damage is known as <strong>hypertensive urgency</strong> and this condition is two to three times more common than hypertensive emergency.</p>
<p>Neurologic end-organ damage due to uncontrolled BP may include hypertensive encephalopathy, cerebral vascular accident/cerebral infarction, <a href="http://emedicine.medscape.com/article/794076-overview"><span data-custom-style="Hyperlink">subarachnoid hemorrhage</span></a>, and/or <a href="http://emedicine.medscape.com/article/1163977-overview"><span data-custom-style="Hyperlink">intracranial hemorrhage</span></a>.<sup> </sup>Cardiovascular end-organ damage may include myocardial ischemia/infarction, acute left ventricular dysfunction, acute pulmonary edema, and/or aortic dissection. Other organ systems may also be affected by uncontrolled hypertension, which may lead to <a href="http://emedicine.medscape.com/article/777845-overview"><span data-custom-style="Hyperlink">acute renal failure</span></a>/insufficiency, retinopathy, <a href="http://emedicine.medscape.com/article/253960-overview"><span data-custom-style="Hyperlink">eclampsia</span></a>, or microangiopathic hemolytic anemia.</p>
<h2 id="target-users">Target users</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Doctors</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Nurses</p>
</div></li>
</ul>
<h2 id="target-area-of-use">Target area of use </h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Ward</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Outpatient department</p>
</div></li>
</ul>
<h2 id="key-areas-of-focus-new-additions-changes">Key areas of focus / New additions / Changes </h2>
<p>This addresses the recognition, symptomatology and approach to the management of acute blood pressure elevations – focusing primarily on adults.</p>
<h2 id="limitations">Limitations</h2>
<p>Efficient ICU and HDU services are largely unavailable within the Gambia. The available range of parenteral antihypertensive medication is limited to labetalol and hydralazine. Troponin testing is also unavailable for routine care.</p>
<p><strong><br />
</strong></p>
<h2 id="clinical-presentations-of-hypertensive-emergencies">Clinical presentations of hypertensive emergencies</h2>
<p>The most common clinical presentations of hypertensive emergencies are</p>
<ol type="1">
<li><div data-custom-style="List Paragraph">
<p>Cerebral infarction</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><a href="http://emedicine.medscape.com/article/157452-overview"><span data-custom-style="Hyperlink">Pulmonary oedema</span></a></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><a href="http://emedicine.medscape.com/article/166129-overview"><span data-custom-style="Hyperlink">Hypertensive encephalopathy</span></a></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><a href="http://emedicine.medscape.com/article/163062-overview"><span data-custom-style="Hyperlink">Congestive heart failure</span></a></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Other clinical presentations associated with hypertensive emergencies include</p>
</div>
<ul>
<li><div data-custom-style="List Paragraph">
<p><a href="http://emedicine.medscape.com/article/1163977-overview"><span data-custom-style="Hyperlink">Intracranial haemorrhage</span></a>,</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Aortic dissection</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><a href="http://emedicine.medscape.com/article/253960-overview"><span data-custom-style="Hyperlink">Eclampsia</span></a></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><a href="http://emedicine.medscape.com/article/155919-overview"><span data-custom-style="Hyperlink">Acute myocardial infarction</span></a></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Retinopathy</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Nephropathy.</p>
</div></li>
</ul></li>
</ol>
<h2 id="history">History</h2>
<p>The history and the physical examination helps to determine the nature, severity, and management of the hypertensive event. The history should focus on the presence of end-organ dysfunction, the circumstances surrounding the hypertension, and any identifiable aetiology.</p>
<p>Please note that patients without target organ damage are usually asymptomatic.</p>
<h3 id="important-parts-of-the-history-are">Important parts of the history are:</h3>
<ul>
<li><div data-custom-style="List Paragraph">
<p>History of acute event: Which event (as listed above), When?, Likely cause? Course? Progression? Precipitating factors? Immediate actions taken? Any previous events-type(s),number &amp; treatments given</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Chest pain – think myocardial ischaemia/infarction or aortic dissection</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Sudden upper back pain – Aortic dissection</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Dyspnoea, Orthopnoea, PND, Palpitations – Pulmonary oedema/Congestive heart failure</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Seizure/Visual disturbance/altered levels of consciousness – Hypertensive encephalopathy</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Focal motor or sensory deficits and speech or visual changes – Stroke</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>The duration and severity of the patient’s pre-existing hypertension (including the degree of BP control)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Any symptom attributable to high blood pressure? Persistent headaches? Unexplained tinnitus? Epistaxis? Dyspnoea? Dizziness? Light-headedness? Atypical chest pain?</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Prior investigations into the cause of the hypertension (if secondary)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Details of antihypertensive drug therapy and compliance,</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Intake of over-the-counter (OTC) preparations such as sympathomimetic agents, and</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Use of illicit drugs such as cocaine are important elements of the medication history.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Presence of previous end-organ dysfunction, particularly renal and cerebrovascular disease</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Presence of any other medical problems (e.g., thyroid disease, <a href="http://emedicine.medscape.com/article/1476919"><span data-custom-style="Hyperlink">Cushing disease</span></a>, <a href="http://emedicine.medscape.com/article/332244-overview"><span data-custom-style="Hyperlink">systemic lupus</span></a>).</p>
</div></li>
</ul>
<p>In female patients, determine the date of their last menstrual period and take a complete history of pregnancy.</p>
<h3 id="history-determination-of-precipitating-factors">History – Determination of Precipitating Factors</h3>
<p>Addressing this has been found to contribute significantly to reducing mortality from acute severe hypertension.</p>
<p>Documented precipitating factors are:</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Non-adherence to prescribed antihypertensive medications is the most common precipitating factor.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Dietary sodium indiscretion;</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Use of prescribed, over-the-counter, or illicit drugs (e.g., cocaine, amphetamines, sympathomimetic agents, nonsteroidal anti-inflammatory drugs, and high-dose glucocorticoids)</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Anxiety or panic</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Acute stroke</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Heart failure</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Acute glomerulonephritis</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Pheochromocytoma</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>For patients on hospital admission, withholding of anti-hypertensive medications, pain, and urinary retention</p>
</div></li>
</ul>
<h2 id="physical-examination-findings">Physical Examination findings</h2>
<p>The physical examination should assess whether end-organ dysfunction is present.</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p><strong>Blood pressure measurement:</strong> BP should not only be measured in both the supine position and the standing position (assess volume depletion), but it should also be measured in both arms (a significant difference may suggest aortic dissection). BP&gt; 180/110-120 reproducible on multiple measurements using an accurate instrument is important to ascertain the diagnosis. This must persist in spite of rest of 20-30 minutes between measurements.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>General examination:</strong> Appearance, level of consciousness, asterixis,</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>End Organ Damage:</strong> Specific Examination</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Fundoscopy:</strong> The presence of new retinal haemorrhages, exudates, or papilledema suggests a hypertensive emergency. Basically searching for evidence of microvascular injury or cerebral oedema (papilledema).</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Cardiovascular system (CVS) exam:</strong> Evaluate for the presence of heart failure, which may be indicated by raised jugular venous distention, third heart sound and crackles/bibasal rales on auscultation ; peripheral oedema.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Central nervous system (CNS) exam:</strong> findings may include changes in the patient&#39;s level of consciousness and visual fields, and/or the presence of focal neurologic signs like motor deficits and gait, speech, and visual abnormalities</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p><strong>Abdominal Examination:</strong> Abdominal masses or bruits may be noted (Aortic dissection)</p>
</div></li>
</ul>
<h2 id="investigations">Investigations</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>ECG – extent of cardiac damage</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Chest X-ray – congestive cardiac failure</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Echo – extent of cardiac damage, aortic dissection</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Electrolytes, urea and creatinine – serum creatinine level to rule out acute kidney injury</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Full Blood Count – anaemia and thrombocytopaenia suggestive of microangiopathy</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Urinalysis – proteinuria or haematuria points to microvascular injury</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>CT Scan – cerebrovascular accident</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Abdominal ultrasound scan, with doppler flow – aortic dissection</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>CT of the chest and abdomen – if dissection of the aorta is not clearly shown on USS for any reason.</p>
</div></li>
</ul>
<p>In the absence of symptoms, the yield of diagnostic tests are insignificant.</p>
<h2 id="treatment">Treatment </h2>
<h3 id="immediate-treatment">Immediate Treatment</h3>
<p>Optimal pharmacotherapy is dependent upon the specific organ at risk. In patients presenting with hypertensive emergencies, antihypertensive drug therapy has been shown to be effective in acutely decreasing BP. The details of which drug is recommended for which condition and the way to dose the drugs which are available to us are outlined in the tables on the next pages.</p>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Ensure patient’s airway is patent.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Ascertain he/she is breathing adequately. Augment with intra-nasal oxygen if need be.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Make sure there are two patent intravenous cannulas through which medications and fluids will be administered.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Admit the patient to the open ward bed directly across the nurse sitting area.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>For adults with a compelling condition (i.e. aortic dissection, severe preeclampsia or eclampsia, or pheochromocytoma crisis), lower SBP to below 140 mmHg during the first hour and to below 120 mmHg in aortic dissection.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>For adults without a compelling condition, reduce the SBP by a maximum of 25% within the first hour; then, if the patient is clinically stable, lower the BP to 160/100 -110 mmHg over the next 2-6 hours, and then cautiously to normal over the following 24-48 hours.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>In hypertensive encephalopathy, aim to reduce the MAP over 8 hours.<sup> </sup></p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>In acute ischaemic stroke, withhold antihypertensive medications unless the SBP is above 220 mmHg or the DBP is over 120 mmHg.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>For adults with aortic dissection, rapidly lower the SBP to below 120 mmHg within 20-30 minutes.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>In phaeochromocytoma, ideally lower the SBP to below 140 mmHg during the first hour, with phentolamine IV bolus dose of 5 mg. Additional bolus doses may be given every 10 minutes as needed to achieve target BP. However, phentolamine is not readily available; alternative means of alpha blockade include doxazosin and magnesium sulphate. Beta blockers can be added for BP control <em>only after</em> alpha blockade.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>In acute intracerebral haemorrhage with signs of increased ICP, maintain the MAP just below 130 mmHg (or SBP &lt; 180 mmHg) for the first 24 hours after onset. In patients without increased ICP, maintain the MAP below 110 mmHg (or SBP &lt; 160 mmHg) for the first 24 hours after symptom onset.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>In adults with acute intracerebral haemorrhage who present with an SBP above 220 mmHg, continuous IV drug and close BP monitoring is reasonable to lower SBP.<sup> </sup>Note that it may be harmful to immediately lower SBP to below 140 mmHg in adults with spontaneous intracerebral haemorrhage who present within 6 hours of the acute event and have an SBP between 150 and 220 mmHg.</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>In women with eclampsia or preeclampsia, the SBP should lowered to below 140 mmHg during the first hour.<sup> </sup></p>
</div></li>
</ul>
<table>
<thead>
<tr class="header">
<th><strong>Hypertensive Emergencies/Conditions</strong></th>
<th><p><strong>Preferred Antihypertensive Agents</strong></p>
<p><em>(Drugs in italics are not readily available to us)</em></p></th>
<th><strong>Medications to avoid/caveats</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Acute Aortic Dissection</td>
<td>Labetalol</td>
<td>Avoid Hydralazine</td>
</tr>
<tr class="even">
<td>Acute Myocardial Ischaemia/Infarction</td>
<td><p>Glyceryl trinitrate +/- Labetalol</p>
<p>Beta blockers</p></td>
<td>Avoid Hydralazine. Avoid giving glyceryl trinitrate with phosphodiesterase type 5 (PDE-5) inhibitors – results in hypotension</td>
</tr>
<tr class="odd">
<td>Acute Left Ventricular Failure or Pulmonary Oedema</td>
<td><p>Glyceryl trinitrate + a loop diuretic</p>
<p>Enalapril</p></td>
<td>Avoid labetalol</td>
</tr>
<tr class="even">
<td>Acute Ischaemic Stroke/Intracerebral Bleed</td>
<td>Labetalol</td>
<td>Avoid Hydralazine</td>
</tr>
<tr class="odd">
<td>Acute Renal Failure</td>
<td><p><em>Fenoldopam</em></p>
<p><em>Nicardipine</em></p>
<p>Labetalol</p></td>
<td></td>
</tr>
<tr class="even">
<td>Hypertensive Encephalopathy</td>
<td>Labetalol</td>
<td>Avoid Hydralazine</td>
</tr>
<tr class="odd">
<td>Pre-Eclampsia or Eclampsia</td>
<td><p>Labetalol</p>
<p>Hydralazine</p>
<p>Magnesium Sulphate</p></td>
<td></td>
</tr>
<tr class="even">
<td>Sympathetic Crisis/Cocaine Overdose</td>
<td><p><em>Phentolamine</em></p>
<p>Magnesium sulphate</p>
<p>Doxazosin</p></td>
<td>Avoid labetalol, unopposed beta blockers</td>
</tr>
<tr class="odd">
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis"><strong>Medication</strong></span></p>
</div></td>
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis"><strong>Dosage</strong></span></p>
</div></td>
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis"><strong>Route</strong></span></p>
</div></td>
</tr>
<tr class="even">
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis">Labetalol</span></p>
</div></td>
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis">20-80 mg IV bolus every 10 mins,0.5-2 mg/min</span></p>
</div></td>
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis">IV</span></p>
</div></td>
</tr>
<tr class="odd">
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis">Magnesium Sulphate</span></p>
</div></td>
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis">6 g loading dose, then 2g/hour</span></p>
</div></td>
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis">IV/Deep IM</span></p>
</div></td>
</tr>
<tr class="even">
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis">Hydralazine</span></p>
</div></td>
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis">10-20 mg</span></p>
</div></td>
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis">IV</span></p>
</div></td>
</tr>
<tr class="odd">
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis">Nitroglycerine (Glyceryl trinitrate)</span></p>
</div></td>
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis">5-100 µg /min</span></p>
</div></td>
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis">Sublingual</span></p>
</div></td>
</tr>
<tr class="even">
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis">Enalapril</span></p>
</div></td>
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis">1.25-5 mg every 6 hours</span></p>
</div></td>
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis">P.O</span></p>
</div></td>
</tr>
<tr class="odd">
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis">Doxazosin</span></p>
</div></td>
<td><div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis">4-12 mg/ day (can be increased to 24 mg/day)</span></p>
</div></td>
<td></td>
</tr>
</tbody>
</table>
<h3 id="delayed-treatment"><span data-custom-style="Emphasis">Delayed Treatment</span></h3>
<div data-custom-style="Normal (Web)">
<p><span data-custom-style="Emphasis">This consists of lifestyle modifications.</span></p>
</div>
<div data-custom-style="Normal (Web)">
<p>It is recommended that to lower BP and decrease cardiovascular disease risk, 2 or more lifestyle modifications should be combined to the pharmacologic treatment:</p>
</div>
<ul>
<li><div data-custom-style="Normal (Web)">
<blockquote>
<p>Weight loss (range of approximate systolic BP reduction [SBP], 5-20 mm Hg per 10 kg)</p>
</blockquote>
</div></li>
<li><div data-custom-style="Normal (Web)">
<blockquote>
<p>Limit alcohol intake to no more than 1 oz (30 mL) of ethanol per day for men or 0.5 oz (15 mL) of ethanol per day for women and people of lighter weight (range of approximate SBP reduction, 2-4 mm Hg)</p>
</blockquote>
</div></li>
<li><div data-custom-style="Normal (Web)">
<blockquote>
<p>Reduce sodium intake to no more than 100 mmol/day (2.4 g sodium or 6 g sodium chloride; range of approximate SBP reduction, 2-8 mm Hg)<sup> </sup></p>
</blockquote>
</div></li>
<li><div data-custom-style="Normal (Web)">
<blockquote>
<p>Maintain adequate intake of dietary potassium (approximately 90 mmol/day)</p>
</blockquote>
</div></li>
<li><div data-custom-style="Normal (Web)">
<blockquote>
<p>Maintain adequate intake of dietary calcium and magnesium for general health</p>
</blockquote>
</div></li>
<li><div data-custom-style="Normal (Web)">
<blockquote>
<p>Stop smoking and reduce intake of dietary saturated fat and cholesterol for overall cardiovascular health</p>
</blockquote>
</div></li>
<li><div data-custom-style="Normal (Web)">
<blockquote>
<p>Engage in aerobic exercise at least 30 minutes daily for most days (range of approximate SBP reduction, 4-9 mm Hg)</p>
</blockquote>
</div></li>
</ul>
<h2 id="key-issues-for-nursing-care">Key Issues for Nursing care</h2>
<ul>
<li><div data-custom-style="List Paragraph">
<p>Counselling on the importance of medication adherence-medicines do not work in people who do not take them!</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Encourage patients to carefully consider imbibing the lifestyle measures that are documented above</p>
</div></li>
<li><div data-custom-style="List Paragraph">
<p>Teach patients how to use their self-monitoring BP machines (where applicable).</p>
</div></li>
</ul>
<h2 id="references">References</h2>
<p>The 2017 American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommendations for hypertensive crises and emergencies</p>
<p>Peixoto AJ Acute severe hypertension New Eng J Med 2019<strong>;381:1843-52.</strong></p>
<p><strong>DOI: 10.1056/NEJMcp1901117</strong></p>
<p>Hopkins C. Hypertensive emergencies. Available from Medscape (emedicine) <a href="https://emedicine.medscape.com/article/1952052-overview"><span data-custom-style="Hyperlink">https://emedicine.medscape.com/article/1952052-overview</span></a>. Accessed on 10<sup>th</sup> November 2019 at 15:17 GMT</p>
<p><span data-custom-style="selectable">Whitelaw B, Prague J, Mustafa O, Schulte K, Hopkins P, Gilbert J et al. Phaeochromocytoma crisis. Clinical Endocrinology. 2013;80(1):13-22.</span></p>
<table>
<thead>
<tr class="header">
<th><strong>Written by:</strong></th>
<th>Name: Babatunde Awokola</th>
<th>Date: 20 November 2019</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Reviewed by:</strong></td>
<td>Name: Fatai Akemokwe</td>
<td>Date: 18 December 2020</td>
</tr>
<tr class="even">
<td><strong>Version:</strong></td>
<td><strong>Change history:</strong></td>
<td><strong>Review due date:</strong></td>
</tr>
<tr class="odd">
<td>1.0</td>
<td>New document</td>
<td>18 December 2022</td>
</tr>
<tr class="even">
<td>Review Comments (<em>if applicable)</em></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>
</article>
</body>
</html>
